MedTrace Logo

Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian Cancer

NCT01538498 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 134

Last updated 2013-03-28

No results posted yet for this study

Summary

* Primary objectives: To develop peritoneal carcinomatosis index (PCI) for ovarian cancer, tubal cancer and primary peritoneal cancer that can represent perioperative intraperitoneal tumor burden objectively
* Secondary objectives: To establish the relationship and find out clinical significance between PCI, tumor location and tumor characteristics

Conditions

Sponsors & Collaborators

  • National Cancer Center, Korea

    lead OTHER_GOV

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2012-11-30
Completion
2013-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01538498 on ClinicalTrials.gov